İlhan ÖZTOP

Chronological Age Is Not an Independent Determinant of Survival or Treatment Access in Metastatic Non–Small Cell Lung Cancer: A Real-World Cohort Study

Güzide Kofalı Ayakdaş, Kübra Canaslan, İlhan ÖZTOP, Elif Atağ

tr (code pays fourni par la source)

The Prognostic Value of Dynamic Changes in Prognostic Nutritional Index (PNI) During Treatment in Lung Cancer: Is Improvement a Better Predictor than Baseline?

Eren Mingsar, İlhan ÖZTOP, Sinan Ünal

Objective: Although the baseline prognostic nutritional index (PNI) is a well-known prognostic factor in lung cancer, the clinical significance of its fluctuation during treatment remains unclear. This study aimed to evaluate the prognostic value of dynamic changes in the PNI and to …

tr (code pays fourni par la source)

Prognostic stratification in gastric cancer with peritoneal metastasis: tumor biology and diagnostic modality as a surrogate for disease burden

Kübra Canaslan, Erkut Demirciler, Sema Çelik, Koray Atila et autres

BACKGROUND: Gastric adenocarcinoma with peritoneal metastasis (PM) has a poor prognosis, yet clinical outcomes vary significantly. This study aimed to identify independent prognostic determinants of PM-specific survival (PM-OS), focusing on tumor biology and disease burden surrogate. METHODS: We retrospectively analyzed 166 patients …

tr (code pays fourni par la source)

The Prognostic Value of Dynamic Changes in Prognostic Nutritional Index (PNI) During Treatment in Lung Cancer: Is Improvement a Better Predictor than Baseline?

Eren Mingsar, İlhan ÖZTOP, Sinan Ünal

Objective Although the baseline Prognostic Nutritional Index (PNI) is a well known prognostic factor in lung cancer, the clinical significance of its fluctuation during treatment remains unclear. This study aimed to evaluate the prognostic value of dynamic changes in PNI and to …

tr (code pays fourni par la source)

The Use of Patient-Reported Outcome Measures in Oncology: Perspectives of Oncologists

Eda Çalışkan Yıldırım, Mehmet Uzun, İlhan ÖZTOP, Tuğba Yavuzşen

ABS TRACT Objective: This survey study was designed with the aim of assessing the use and opinions about patient-reported outcome measures (PROM) by healthcare workers in oncology clinics in Türkiye.Material and Methods: A 10-question survey was distributed to medical and radiation oncologists …

tr (code pays fourni par la source)

Third-line Therapy for Metastatic Renal Cell Carcinoma and Its Effect on Quality of Life and Overall Survival: A National, Multicenter, Observational Study

İrfan Çiçin, Aydın Çiltaş, Saadettin Kılıçkap, Berna Öksüzoğlu et autres

ABS TRACT Objective:The study aimed to evaluate the efficacy of targeted therapies used as the third-line treatment after first-line cytokine and second-line tyrosine kinase inhibitor (TKI) therapies in metastatic renal cell carcinoma (mRCC) patients and assess the quality of life (QoL) of …

tr, gb (code pays fourni par la source)

Clinical and pathological features of patients with resected synovial sarcoma: A multicenter retrospective analysis of the Anatolian Society of Medical Oncology

Tarkan Yetişyiğit, Erkan Arpacı, ErdoganSeber Selcuk, Mehmet Küçüköner et autres

BACKGROUND: Synovial sarcoma (SS) is a rare disease and compared with other soft-tissue sarcomas has a relatively high mortality rate. The optimal management of this disease and prognostic factors associated with patient outcome remains controversial. AIMS: We aimed to evaluate the factors …

tr (code pays fourni par la source)

metastatik kolorektal kanserli hastalarda Bevasizumab kombinasyonlu kemoterapi rejimlerinin ikinci ve sonraki basamaklarda etkinlik ve tolerabilitesinin reyropektif olarak değerlendirilmesi:ATOD deneyimi

Lokman Koral, Mustafa Beneklı, Mahmut Gumus, Melih Cem Börüban et autres